Pharmacogenomics Is A Field Of Medicine That Studies How Genes Can Affect Response To Drugs And It Can Be Used For Creating Targeted Therapies
Pharmacogenomics |
Pharmacogenomics is an emerging field in which genes,
proteins and single nucleotide polymorphisms (SNPs) are studied to determine
how people respond to specific drugs. This research will allow drug makers to
create targeted therapies that target the disease and not just the symptoms.
The most common use of Pharmacogenomics
is to identify the right drug for each individual patient, reducing the number
of patients prescribed different drugs that may not work well for them or cause
unwanted side effects. This is called personalized medicine. It can save time
and money, as there is no need to go through trial-and-error with multiple
medications until the right one is found.
People respond
differently to medicines, some get better and others have no effect or side
effects. Doctors use this information to find the best way to treat each
person. Its part of the new field called precision medicine.
Using Pharmacogenomics to help find new ways
of treating diseases is a big part of the field of "precision
medicine." These medicines can be made only for people with specific
genetic traits or a disease that's caused by those traits.
Pharmacogenomics
can help doctors choose the best drug for an individual patient and avoid
giving them too many of them that aren't likely to work. This will save
patients money and reduce the number of medications they need to take. It will
also help doctors select the best drugs for patients with chronic illnesses.
This will save them time and reduce the number of medications they need to give
each day.
Pharmacogenomics is a
rapidly growing field that can be applied to many different aspects of medical
care, from finding the best drug for an individual to making sure the right
dose is given. It also can help doctors figure out which drugs will not cause
problems for someone with a certain gene and which ones may cause serious side
effects.
Predicting how a drug will react to a patient's genetic
makeup is a challenge, as people often respond differently to different
medicines. Some people may not have any symptoms at all when they are given a
drug while others will have severe reactions that could require hospitalization
or death.
Another major challenge is to predict when a company will
need to develop a companion diagnostic assay to complement the drug. The goal
of a companion diagnostic assay is to help doctors prescribe the correct dose
of a drug to each individual patient. If this is not done, then many patients will
experience side effects and won't get the full benefits of the drug.
The
expanded Invitae Pharmacogenomics (PGx) Panel was launched by Invitae
in May 2022. The panel includes specialized Invitae Pharmacogenomics Mental
Health Panel.
Comments
Post a Comment